| Bioactivity | Uridine adenosine tetraphosphate (UP4A) is an endothelium-derived vasoconstrictor that primarily acts through the P2X1 receptor and possibly through the P2Y2 and P2Y4 receptors. Uridine adenosine tetraphosphate can be used in the study of cardiovascular diseases[1]. |
| CAS | 10527-48-7 |
| Formula | C19H27N7O21P4 |
| Molar Mass | 813.35 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Jankowski, et al. "Uridine adenosine tetraphosphate: a novel endothelium-derived vasoconstrictive factor." Nature medicine 11.2 (2005): 223-227. |
Uridine adenosine tetraphosphate
CAS: 10527-48-7 F: C19H27N7O21P4 W: 813.35
Uridine adenosine tetraphosphate (UP4A) is an endothelium-derived vasoconstrictor that primarily acts through the P2X1 r
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.